secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001193125-26-029326
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q2 FY2026: Revenue $1.42B (+11% YoY), non-GAAP EPS $2.81, dividend $0.60
-------------------------------------------------------------------------------

- Revenue $1,422.8M, up 11% YoY (9% constant currency); gross margin expanded 320 bps to 61.8%.
- GAAP diluted EPS $2.68; non-GAAP diluted EPS $2.81, up 16% YoY.
- Operating cash flow $340M; income from operations rose 18% YoY.
- Board declared quarterly cash dividend of $0.60/share, record Feb 12, payable Mar 19.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/0001193125-26-029326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526029326/d80310d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-029326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer